With India joining, the global partnership working to address challenges and improve coordination and collaboration in AMR R&D is expanded. Membership now consists of 16 countries, the European Commission, 2 philanthropic foundations and 4 international organisations (as observers).
04.02.2025
New Publication in Vaccine
Vaccines play a vital role in preventing infections and reducing antibiotic use, making them essential tools in the fight against antimicrobial resistance (AMR). Given that AMR disproportionately impacts Low- and Middle-Income Countries (LMICs), this study provides this first comprehensive analysis of global investments in bacterial vaccine research and development (R&D) in LMICs.